TD Asset Management’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-22,758
| Closed | -$275K | – | 1436 |
|
|
2023
Q3 | $275K | Hold |
22,758
| – | – | ﹤0.01% | 1350 |
|
|
2023
Q2 | $241K | Hold |
22,758
| – | – | ﹤0.01% | 1359 |
|
|
2023
Q1 | $224K | Hold |
22,758
| – | – | ﹤0.01% | 1369 |
|
|
2022
Q4 | $335K | Sell |
22,758
-6,505
| -22% | -$95.7K | ﹤0.01% | 1341 |
|
|
2022
Q3 | $352K | Sell |
29,263
-5,445
| -16% | -$65.5K | ﹤0.01% | 1350 |
|
|
2022
Q2 | $486K | Sell |
34,708
-13,822
| -28% | -$194K | ﹤0.01% | 1297 |
|
|
2022
Q1 | $691K | Sell |
48,530
-19,298
| -28% | -$275K | ﹤0.01% | 1298 |
|
|
2021
Q4 | $1.43M | Buy |
67,828
+22,928
| +51% | +$483K | ﹤0.01% | 1210 |
|
|
2021
Q3 | $1.18M | Hold |
44,900
| – | – | ﹤0.01% | 1213 |
|
|
2021
Q2 | $1.5M | Buy |
+44,900
| New | +$1.5M | ﹤0.01% | 1165 |
|